Blog

Kimryn Rathmell: Beyond the Headlines – The Real Impact of Early Onset Cancer

Kimryn Rathmell/nih.gov

May 16, 2025, 06:00

Kimryn Rathmell: Beyond the Headlines – The Real Impact of Early Onset Cancer

Kimryn Rathmell, CEO of Ohio State’s James Cancer Hospital and Solove Research Institute, posted on LinkedIn:

“Early onset cancer is on the rise. This is a signal that is important to pay attention to,

1) because it signals a health problem that we aren’t able to control effectively yet, and
2) because this is a signal that is teaching us about cancer in general.

The first thing we need is data – who is this impacting, where, when, and how. A powerful new study (linked below) has compiled the data from across the U.S. cancer landscape, finding 14 cancers rising in younger age groups. Some are notably rising in younger ages, and others are rising across the lifespan.

The next thing we need to do is have this issue out in the open so we can talk about it, develop plans to understand and approach it, and to be sure our tactics are meeting the needs of the community.

I would encourage people to read the Cancer Currents blog this week to get a grasp of the topic, and join us at ASCO25 for a deep discussion of early onset cancer where we’ll talk “Beyond the Headlines: The real impact of early onset cancer”

Title: Trends in Cancer Incidence and Mortality Rates in Early-Onset and Older-Onset Age Groups in the United States, 2010–2019

Authors: Meredith S. Shiels, Anika T. Haque, Amy Berrington de González, M. Constanza Camargo, Megan A. Clarke, Brittny C. Davis Lynn, Eric A. Engels, Neal D. Freedman, Gretchen L. Gierach, Jonathan N. Hofmann, Rena R. Jones, Erikka Loftfield, Rashmi Sinha, Lindsay M. Morton, Stephen J. Chanock

Read The Full Article at AACR Journals.

Kimryn Rathmell: Beyond the Headlines - The Real Impact of Early Onset Cancer

More posts featuring Kimryn Rathmell .

Amy Berrington de González Anika T. Haque ASCO25 Brittny C. Davis Lynn cancer early-onset cancer Eric A. Engels Erikka Loftfield Gretchen L. Gierach Jonathan N. Hofmann Kimryn Rathmell Lindsay M. Morton M. Constanza Camargo Megan A. Clarke Meredith S Shiels Neal D. Freedman OncoDaily Oncology Rashmi Sinha Rena R. Jones Stephen J. Chanock

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress

Tabelecleucel (Ebvallo) FDA Update: Approval Delayed Despite Positive Phase 3 Data

New Paper Alert: Breakthrough iNKT Cell Therapy Achieves Complete Remission in Metastatic Germ Cell Tumor

"God Invented This" - Pat Soon-Shiong on Cancer Discovery

Kevin Conroy: Oncodetect is Now Covered by Medicare in Stage IV Colorectal Cancer